Suresh Senan

6PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Instruments and techniquesTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 22, 2026
Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trial.

|Nov 28, 2025
Immune-modulating effects on tumor-draining lymph nodes of neoadjuvant chemoradiotherapy combined with dual immunotherapy in patients with T3-4N0-2 NSCLC.

Ezgi B Ulas, Sofie J I Koomen, Anne Vrijmoet

|Sep 30, 2024
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study.

Idris Bahce, Chris Dickhoff, Famke L Schneiders

|Feb 22, 2023
Comparison of MR-guided radiotherapy accumulated doses for central lung tumors with non-adaptive and online adaptive proton therapy.

Moritz Rabe, Miguel A Palacios, John R van Sörnsen de Koste

|Feb 02, 2022
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.

David R Spigel, Corinne Faivre-Finn, Jhanelle E Gray

|Jul 06, 2021
Finding the Goldilocks zone in neoadjuvant radioimmunotherapy.

Famke L Schneiders, Suresh Senan

Pageof 1

Frequent Collaborators

3 joint publications

Marieke F Fransen

3 joint publications

Febe van Maldegem

3 joint publications

Ezgi B Ulas

3 joint publications

Idris Bahce